USE OF AMI-227 AS AN ORAL MR CONTRAST AGENT

被引:10
|
作者
ROGERS, J
LEWIS, J
JOSEPHSON, L
机构
[1] Advanced Magnetics Inc., Cambridge, MA 02138
关键词
CONTRAST MEDIA; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; ORAL; BRIGHTENING; DARKENING;
D O I
10.1016/0730-725X(94)92458-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We report the use of an ultrasmall superparamagnetic iron oxide colloid AMI-227 as an oral contrast agent. Due to the small size, AMI-227 has a larger effect on T(1) than larger superparamagnetic iron oxides colloids like ferumoxsil, At 2 T, AMI-227 had an R(2)/R(1) of 11.4 compared with an R(2)/R(1) for the superparamagnetic iron oxide ferumoxsil of 179. The R(1)s of the two agents were 7.1 and 1.6 mM(-1) s(-1), for AMI-227 and ferumoxsil, respectively. Due to its smaller R(2)/R(1), orally administered AMI-227 can produce brightening or darkening of the lumen of the GI tract, depending on instrument parameters. At 1 mM Fe, image brightening (2 T, TR = 300, TE = 25) or image darkening of the GI tract (2 T, TR = 1500, TE = 80) was obtained. The ability of AMI-227 to produce either image brightening or darkening suggests it may be useful as an MR contrast agent for the GI tract.
引用
收藏
页码:631 / 639
页数:9
相关论文
共 50 条
  • [1] THE USE OF AMI-227 AS AN ORAL CONTRAST AGENT FOR MAGNETIC-RESONANCE-IMAGING
    ROGERS, J
    LEWIS, J
    JOSEPHSON, L
    INVESTIGATIVE RADIOLOGY, 1994, 29 : S81 - S82
  • [2] Application of superparamagnetic iron oxide (AMI-227) for 3D phase-contrast MR angiography
    Tanimoto, A
    Yuasa, Y
    Hiramatsu, K
    ACADEMIC RADIOLOGY, 1998, 5 : S113 - S115
  • [3] MR LYMPHOGRAPHY WITH IRON-OXIDE COMPOUND AMI-227 - STUDIES IN FERRETS WITH FILARIASIS
    TANOURA, T
    BERNAS, M
    DARKAZANLI, A
    ELAM, E
    UNGER, E
    WITTE, MH
    GREEN, A
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1992, 159 (04) : 875 - 881
  • [4] Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: Experimental study in rabbits
    Loubeyre, P
    Zhao, SH
    Canet, E
    Abidi, H
    Benderbous, S
    Revel, D
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 1997, 7 (06) : 958 - 962
  • [5] BLOOD-POOL MR CONTRAST MATERIAL FOR DETECTION AND CHARACTERIZATION OF FOCAL HEPATIC-LESIONS - INITIAL CLINICAL-EXPERIENCE WITH ULTRASMALL SUPERPARAMAGNETIC IRON-OXIDE (AMI-227)
    SAINI, S
    EDELMAN, RR
    SHARMA, P
    LI, W
    MAYOSMITH, W
    SLATER, GJ
    EISENBERG, PJ
    HAHN, PF
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1995, 164 (05) : 1147 - 1152
  • [6] Monitoring radiation induced changes in bone marrow histopathology with AMI-227 (Sinerem) enhanced MRI
    Daldrup, HE
    Link, TM
    Richter, KD
    Koenemann, S
    Rummeny, EJ
    RADIOLOGY, 1998, 209P : 267 - 267
  • [7] VISUALIZATION OF SUPERIOR MESENTERIC LYMPH-NODES BY THE COMBINED ORAL AND INTRAVENOUS ADMINISTRATION OF THE ULTRASMALL SUPERPARAMAGNETIC IRON-OXIDE, AMI-227
    ROGERS, JM
    LEWIS, J
    JOSEPHSON, L
    MAGNETIC RESONANCE IMAGING, 1994, 12 (08) : 1161 - 1165
  • [8] ORAL HEPATOBILIARY MR IMAGING CONTRAST AGENT
    NELSON, JA
    SCHMIEDL, UP
    KASTELL, M
    ROBINSON, DH
    STARR, FL
    RADIOLOGY, 1992, 185 : 187 - 187
  • [9] Negative oral contrast agent improves MR cholangiopancreatography
    Chauhan, AM
    Thomsen, C
    RADIOLOGY, 2001, 221 : 120 - 120
  • [10] MR cholangiopancreatography and MR urography: Improved enhancement with a negative oral contrast agent
    Hirohashi, S
    Hirohashi, R
    Uchida, H
    Kitano, S
    Ono, W
    Ohnishi, H
    Nakanishi, S
    RADIOLOGY, 1997, 203 (01) : 281 - 285